Clinical Trials Logo

Clinical Trial Summary

The research aims to the primary hepatic carcinoma patients whose diameter of the single tumor is equal or less than 5cm.By supervising the changes of liver function, Child-Pugh score, ICG-R15 value, secondary reaction, incidence rate of RILD during and after the radiotherapy, meanwhile combining the outcome of the progression of disease and the condition of survival quality, the optimum proposal could be obtained and apply to clinic thus make the treatment safe, effective and personalized.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03295500
Study type Observational
Source Beijing 302 Hospital
Contact
Status Completed
Phase
Start date November 1, 2017
Completion date September 24, 2021